Diospyros anisandra
Diospyros anisandra · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Diospyros anisandra is a botanical species recognized for its significant therapeutic potential in traditional medicine. Research indicates that the stem of this plant serves as a primary source for bioactive compounds. Specifically, the non-polar extract of the stem contains naphthoquinones, which are critical chemical constituents. These substances provide potent anti-infective properties, making the plant a subject of interest for pharmacological study. Consequently, Diospyros anisandra demonstrates effective anthelmintic activities against various parasitic threats.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Ebenaceae
- Distribution
- Not available
- Plant Parts
- Stem
Classification
Common Names
Diospyros anisandra is a remarkable species known locally by its distinctive common name, x-nob-ché. This botanical identity connects the plant deeply to the cultural heritage and linguistic traditions of its native environment. Recognizing it by this name allows researchers and local inhabitants to communicate with precision and shared understanding. Such nomenclature highlights the vital relationship between human language and the natural world. Through this specific designation, the plant becomes more than just a specimen, embodying a unique piece of regional identity.
Sources: Catalogue of Life (COL)
Taxonomy
Diospyros anisandra belongs to the vast kingdom Plantae, marking its place among the diverse living organisms on Earth. Within this expansive group, the species is classified under the class Equisetopsida. It further falls into the order Ericales, showcasing its specific evolutionary lineage. This plant is a distinguished member of the genus Diospyros, a group known for its unique characteristics. Ultimately, it is nested within the Ebenaceae family, completing its complex biological identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Ebenaceae |
| Genus | Diospyros |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Diospyros anisandra exhibits a vast geographic range that spans across several major regions of the Americas. In the north, its distribution reaches into Mexico and the southeastern parts of the country. Moving southward, the species is widely established throughout Central America, including countries like Guatemala. Its presence extends even further into the Caribbean, where it can be found throughout Cuba. Ultimately, this diverse distribution highlights the plant's ability to thrive across both Northern and Southern American landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Diospyros anisandra is a self-supporting plant that takes the form of a tree. This sturdy growth habit allows it to stand independently within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Diospyros anisandra has emerged as a plant of significant interest due to its demonstrated anthelmintic potential. Recent research indicates that this species holds a promising prospect for combating Ancylostoma caninum, a major hookworm affecting canine populations. This is particularly relevant given the rising concerns regarding anthelmintic resistance in dogs, especially in regions like Indonesia where prevalence is high. While current studies have highlighted its efficacy in in vitro settings, further investigation is required to validate these findings. Moving forward, essential in vivo trials must be conducted to ensure the safety and clinical effectiveness of this plant for practical veterinary applications.
Compounds
Diospyros anisandra serves as a rich natural source of bioactive compounds that hold significant promise for pharmaceutical development. Research has identified that the plant contains several naphthoquinones, which exhibit potent activity against drug-resistant strains of Mycobacterium tuberculosis. Among these isolated compounds, plumbagin has been highlighted for its strong inhibitory effects against both sensitive and resistant tuberculosis strains. Additionally, the plant contains maritinone, a dimer that demonstrates remarkable potency and a favorable safety profile in cellular studies. These chemical relationships underscore the medicinal potential of D. anisandra in the urgent search for new anti-tuberculosis drugs.
Conditions
Diospyros anisandra exhibits significant medicinal potential as an anthelmintic agent against the hookworm Ancylostoma caninum. Research indicates that the plant possesses potent anti-TB activity through the isolation of various naphthoquinones. These compounds serve as promising candidates for the development of new anti-TB drugs to combat rising resistance. Furthermore, the plant acts as a valuable source for developing novel anti-infective agents. This effectiveness is particularly notable in treating extensively drug-resistant (XDR) and pan-resistant strains of Mycobacterium tuberculosis.
Preparations
Diospyros anisandra is prepared as a non-polar extract to facilitate the isolation of bioactive compounds. This specific n-hexane crude extract is obtained from the stem bark of the plant through a process of maceration and liquid-liquid fractionation. The resulting non-polar extract has previously demonstrated potent anti-tuberculosis activity in medicinal studies. From this preparation, researchers successfully isolated eight different naphthoquinones, including monomeric and dimeric forms. These extracted molecules, such as maritinone and 3,3'-biplumbagin, show significant potential for treating drug-resistant strains of Mycobacterium tuberculosis.
Parts used
Diospyros anisandra serves as a vital source of medicinal compounds, particularly through the utilization of its stem bark. Researchers have successfully extracted naphthoquinones from the stem to investigate their therapeutic potential against various pathogens. These specific molecules have demonstrated potent activity against pan-resistant strains of Mycobacterium tuberculosis, which pose a significant global health threat. Notably, the dimers maritinone and 3,3'-biplumbagin found in the plant exhibited much higher potency than traditional drugs like rifampicin. Because these compounds also showed low toxicity to mammalian cells, the stem of this plant offers a promising foundation for developing new anti-tuberculosis treatments.